Talk:Gingipain

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of molecular biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology
???	This article has not yet received a rating on the project's importance scale.
	This article is supported by the Molecular and Cell Biology task force (assessed as Low-importance).

Chemicals Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals
Low	This article has been rated as Low-importance on the project's importance scale.

Gingipain mentioned

Latest comment: 7 years ago1 comment1 person in discussion

See an article from 23 January 2019 in the New Scientist. See also a press release from a company named Cortexyme (24 October 2018) which is developing what seems to be a gingipain blocker (COR-388) and is planning a clinical trial. There is said to be a connection of gingipain with Alzheimers. At present we have no article on Cortexyme, but its name is mentioned as a recipient of a grant from the Thiel Foundation in our article on Breakout Labs. EdJohnston (talk) 17:34, 24 January 2019 (UTC)Reply